Physician profile
Stephen M Scheper
NPI 1144402561
$3,531.75
in general payments reported to CMS, 2019-2025
21 companies · $479 in 2025
The $479 reported for 2025 was more than what 78% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $671 · 2020: $730 · 2021: $442 · 2022: $199 · 2023: $415 · 2024: $595 · 2025: $479.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,342 · Travel and Lodging: $148.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,341.75 |
| Travel and Lodging | $147.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $2,006.52 | 2019-2024 | Senza |
| Spr Therapeutics, INC | $383.61 | 2023-2024 | Sprint Pns System |
| Medtronic, INC. | $268.30 | 2025 | Inceptiv |
| Boston Scientific Corporation | $200.06 | 2019-2025 | Intracept |
| Abbott Laboratories | $104.10 | 2022-2025 | Eterna, Proclaim |
| Almatica Pharma LLC | $96.71 | 2020-2021 | |
| Globus Medical, INC. | $88.26 | 2025 | Senza |
| Scilex Pharmaceuticals INC. | $48.73 | 2020-2024 | Ztlido |
| Si-Bone, INC. | $46.44 | 2020 | |
| Ibsa Pharma INC. | $45.83 | 2021 | |
| Abbvie INC. | $37.91 | 2023 | Botox |
| Arbor Pharmaceuticals, INC. | $36.74 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $33.94 | 2019-2020 | |
| Pfizer INC. | $23.51 | 2023 | |
| Merz North America, INC. | $22.23 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ipsen Biopharmaceuticals, INC | $17.20 | 2021 | |
| Stryker Corporation | $17.00 | 2023 | Multigen 2 |
| Novartis Pharmaceuticals Corporation | $16.47 | 2019 | |
| Biodelivery Sciences International, INC. | $14.39 | 2020 | |
| Mdd US Operations, LLC | $12.01 | 2019 | |
| Otto Bock Healthcare LP | $11.79 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Scheper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.